New hope for heart patients: dabigatran tested against warfarin in High-Risk group
NCT ID NCT04045093
First seen Jan 10, 2026 · Last updated Jun 14, 2026 · Updated 21 times
Summary
This study tests whether the blood thinner dabigatran is as safe and effective as warfarin for preventing strokes in people with atrial fibrillation (irregular heartbeat) and moderate to severe mitral stenosis (narrowed heart valve). About 370 adults will take either dabigatran or warfarin and be monitored for strokes, blood clots, heart attacks, and heart-related deaths. The goal is to find a better treatment option for this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Hong Kong / Queen Mary Hospital
Hong Kong, Hong Kong
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.